News201720162015 17 Aug 2017 Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527 Yes 7 Aug 2017 Alligator expands immuno-oncology collaboration with Stanford University No 21 Jul 2017 Aptevo Therapeutics and Alligator Bioscience announce plans to co-develop novel bispecific antibody for tumor-directed immunotherapy Yes 12 Jun 2017 Alligator advances 4-1BB immuno-oncology antibody ATOR-1017 to pre-clinical development Yes 4 May 2017 Alligator Bioscience presents promising immuno-oncology data at US conference; – Strong new preclinical findings for ADC-1013 and ATOR-1015 Yes 2 May 2017 Bulletin from the annual shareholders’ meeting in Alligator Bioscience AB (publ) on May 2, 2017 Yes 2 May 2017 Alligator Bioscience AB Interim report January-March 2017 Yes 28 Apr 2017 Alligator Bioscience to present new pre-clinical data for ADC-1013 and ATOR-1015 at PEGS conference in Boston, May 4 No 31 Mar 2017 Change in number of shares and votes in Alligator Bioscience AB (publ) Yes 12› 30 Dec 2016 Change in number of shares and votes in Alligator Bioscience AB (publ) No 23 Dec 2016 Exercise of over-allotment option and notice of stabilisation in Alligator Bioscience No 16 Dec 2016 Notice of stabilisation measures No 9 Dec 2016 Notice of stabilisation measures No 30 Nov 2016 Change in number of shares and votes in Alligator Bioscience AB No 23 Nov 2016 Trading of Alligator Bioscience AB on Nasdaq Stockholm commences today Yes 14 Nov 2016 Alligator Bioscience AB publishes prospectus for Initial Public Offering on Nasdaq Stockholm No 2 Nov 2016 Nomination committee appointed in respect of AGM 2017 in Alligator Bioscience AB (Publ) No 2 Nov 2016 Alligator Bioscience AB intends to list its shares on Nasdaq Stockholm No 12› 12 Aug 2015 Alligator Bioscience Announces Collaboration with Johnson & Johnson Innovation for the CD40 Agonistic Immuno-Oncology Antibody ADC-1013 No 27 Apr 2015 First Patient Dosed by Alligator Bioscience in a Clinical Phase 1 Multicenter Trial 7 Apr 2015 Alligator Bioscience Starts a Clinical Phase 1 Multicenter Trial
